Cinctive Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cinctive Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.68M	Buy	+110,079	New	+$6.42M	0.44%	77
2025 Q1	–	Sell	-228,343	Closed	-$12.9M	–	333
2024 Q4	$12.9M	Sell	228,343 -60,105	-21%	-$3.36M	0.66%	37
2024 Q3	$14.9M	Buy	+288,448	New	+$13.5M	0.81%	25
2021 Q2	–	Sell	-261,083	Closed	-$16.5M	–	509
2021 Q1	$16.5M	Buy	261,083 +40,537	+18%	+$2.52M	1.01%	5
2020 Q4	$13.7M	Buy	220,546 +25,703	+13%	+$1.58M	1.12%	3
2020 Q3	$11.7M	Buy	194,843 +43,839	+29%	+$2.64M	1.03%	4
2020 Q2	$8.88M	Buy	151,004 +52,318	+53%	+$3.13M	1.02%	7
2020 Q1	$5.5M	Sell	98,686 -26,114	-21%	-$1.6M	1.22%	12
2019 Q4	$8.01M	Buy	+124,800	New	+$7.15M	0.84%	25

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cinctive Capital Management's BMY Position: Q1 2026 in Review

Cinctive Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 110,079 shares worth $6.68M. The stake represents 0.44% of the portfolio and ranks #77 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in BMY as recently as Q4 2024.

Cinctive Capital Management first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $16.5M in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Cinctive Capital Management held 110,079 shares of Bristol-Myers Squibb worth $6.68M as of Q1 2026.
Bristol-Myers Squibb was a new Cinctive Capital Management position in Q1 2026.
Bristol-Myers Squibb made up 0.44% of Cinctive Capital Management's portfolio in Q1 2026, its #77 holding.
Cinctive Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
Cinctive Capital Management's Bristol-Myers Squibb position peaked at $16.5M in Q1 2021.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.